Related references
Note: Only part of the references are listed.Heart Disease and Stroke Statistics-2012 Update A Report From the American Heart Association
Veronique L. Roger et al.
CIRCULATION (2012)
Resveratrol Modulates Interleukin-1β-induced Phosphatidylinositol 3-Kinase and Nuclear Factor κB Signaling Pathways in Human Tenocytes
Franziska Busch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Cellular and molecular effects of resveratrol in health and disease
Wei Yu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Treatment with low-dose resveratrol reverses cardiac impairment in obese prone but not in obese resistant rats
Xavier L. Louis et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
Resveratrol Inhibits Inflammatory Responses via the Mammalian Target of Rapamycin Signaling Pathway in Cultured LPS-Stimulated Microglial Cells
Lian-Mei Zhong et al.
PLOS ONE (2012)
Resveratrol prevents norepinephrine induced hypertrophy in adult rat cardiomyocytes, by activating NO-AMPK pathway
Sijo J. Thandapilly et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Temporal relation of cardiac hypertrophy, oxidative stress, and fatty acid metabolism in spontaneously hypertensive rat
Sreeja Purushothaman et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Resveratrol and health - A comprehensive review of human clinical trials
James M. Smoliga et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
Oxidative Stress and Inflammation in Heart Disease: Do Antioxidants Have a Role in Treatment and/or Prevention?
Fredric J. Pashkow
INTERNATIONAL JOURNAL OF INFLAMMATION (2011)
Left Ventricular Hypertrophy: Major Risk Factor in Patients with Hypertension: Update and Practical Clinical Applications
Richard E. Katholi et al.
INTERNATIONAL JOURNAL OF HYPERTENSION (2011)
Resveratrol and Small Artery Compliance and Remodeling in the Spontaneously Hypertensive Rat
John Behbahani et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
Resveratrol Prevents the Development of Pathological Cardiac Hypertrophy and Contractile Dysfunction in the SHR Without Lowering Blood Pressure
Sijo J. Thandapilly et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
Resveratrol Arrests and Regresses the Development of Pressure Overload- but Not Volume Overload-Induced Cardiac Hypertrophy in Rats
Peter Wojciechowski et al.
JOURNAL OF NUTRITION (2010)
Resveratrol Prevents the Prohypertrophic Effects of Oxidative Stress on LKB1
Vernon W. Dolinsky et al.
CIRCULATION (2009)
Validation of Volume-Pressure Recording Tail-Cuff Blood Pressure Measurements
Minjie Feng et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
Pregnancy reverses hypertensive remodeling of cerebral arteries
Marilyn J. Cipolla et al.
HYPERTENSION (2008)
Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: Correlated with NO-cGMP signaling pathway
ShiJun Wang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol
Danijel Juric et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Mechanisms of disease:: oxidative stress and inflammation in the pathogenesis of hypertension
Nosratola D. Vaziri et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2006)
Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension
Justin L. Grobe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Effects of intravenous ABT-870 (iron (III)-hydroxide of oligosaccharide) on mean arterial pressure and heart rate in the anaesthetized beagle: Comparison with other iron-containing haematinic agents
LC Preusser et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2005)
A comparative serial echocardiographic analysis of cardiac structure and function in rats subjected to pressure or volume overload
EJF Cantor et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol
ER Olson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways
HL Li et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Blood pressure-independent attenuation of cardiac hypertrophy by AT1R-AS gene therapy
AS Pachori et al.
HYPERTENSION (2002)